Close



Apr 2, 2024 08:00AM
Mar 27, 2024 10:23AM
Mar 12, 2024 07:30AM
Mar 12, 2024 07:30AM
Feb 27, 2024 04:03PM
Feb 26, 2024 08:00AM
Feb 7, 2024 08:00AM Pliant Therapeutics to Participate in Upcoming Investor Events
Feb 5, 2024 05:50AM
Feb 4, 2024 03:29PM
Jan 3, 2024 08:00AM
Nov 13, 2023 04:30PM
Nov 9, 2023 04:05PM
Nov 8, 2023 08:00AM
Nov 6, 2023 08:00AM Pliant Therapeutics Presentations at the Annual Meeting of the Society for Immunotherapy of Cancer Highlight PLN-101095, A Novel Inhibitor of Integrins αvβ8 and αvβ1
Oct 31, 2023 04:03PM
Oct 19, 2023 08:00AM
Oct 16, 2023 04:05PM
Sep 26, 2023 07:30AM
Sep 26, 2023 07:30AM
Sep 25, 2023 04:05PM
Sep 15, 2023 08:01AM Pliant Therapeutics (PLRX) Appoints Minnie Kuo as Chief Development Officer
Sep 15, 2023 08:00AM
Sep 11, 2023 08:00AM
Aug 30, 2023 08:00AM
Aug 28, 2023 04:05PM
Aug 9, 2023 04:03PM
Aug 9, 2023 08:00AM
Jul 25, 2023 08:00AM Pliant Therapeutics to Participate in Upcoming Investor Conferences
Jun 23, 2023 07:30AM
May 24, 2023 08:04AM
May 24, 2023 08:00AM
May 10, 2023 08:05AM
May 9, 2023 04:02PM
May 1, 2023 05:22AM
Apr 30, 2023 02:10PM Pliant Therapeutics Announces Positive Long-Term Data from the INTEGRIS-IPF Phase 2a Trial Demonstrating Bexotegrast was Well Tolerated at 320 mg with Durable Improvement Shown in FVC and Across Multi
Apr 30, 2023 02:10PM
Apr 12, 2023 08:01AM
Apr 12, 2023 08:01AM
Mar 27, 2023 08:01AM
Mar 27, 2023 08:01AM
Mar 13, 2023 08:02AM
Mar 13, 2023 08:01AM Pliant Therapeutics Announces Positive DSMB Safety Review and Initiation of Enrollment of Phase 2a Trial of Bexotegrast (PLN-74809) at 320 mg Dose in Primary Sclerosing Cholangitis
Mar 13, 2023 08:01AM
Mar 9, 2023 04:05PM
Mar 9, 2023 04:05PM
Mar 8, 2023 04:01PM
Mar 8, 2023 04:01PM
Mar 1, 2023 08:01AM
Mar 1, 2023 08:01AM Pliant Therapeutics to Participate in Upcoming Investor Events
Feb 7, 2023 08:01AM

251,349 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All